MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
30.31
-0.33 (-1.08%)
At close: Apr 28, 2026, 4:00 PM EDT
30.31
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:01 PM EDT
MapLight Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 30.73 | 14.42 | 7.61 | 4.1 |
| Research & Development | 138.35 | 68.52 | 49.68 | 27.14 |
| Operating Expenses | 169.08 | 82.95 | 57.28 | 31.25 |
| Operating Income | -169.08 | -82.95 | -57.28 | -31.25 |
| Interest & Investment Income | 5.52 | 4.5 | 1.1 | 0.43 |
| Earnings From Equity Investments | - | -0.99 | 0.99 | - |
| Currency Exchange Gain (Loss) | - | - | - | 0 |
| Other Non Operating Income (Expenses) | 0.31 | 0.11 | -0.51 | 0.8 |
| EBT Excluding Unusual Items | -163.25 | -79.32 | -55.71 | -30.02 |
| Gain (Loss) on Sale of Investments | 2.1 | 1.74 | - | - |
| Pretax Income | -161.15 | -77.58 | -55.71 | -30.02 |
| Net Income | -161.15 | -77.58 | -55.71 | -30.02 |
| Net Income to Common | -161.15 | -77.58 | -55.71 | -30.02 |
| Shares Outstanding (Basic) | 9 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 9 | 1 | 1 | 1 |
| Shares Change (YoY) | 1079.16% | 11.60% | 18.43% | - |
| EPS (Basic) | -18.56 | -105.38 | -84.45 | -53.89 |
| EPS (Diluted) | -18.56 | -105.38 | -84.45 | -53.89 |
| Free Cash Flow | -138.61 | -79.59 | -52.47 | -27.32 |
| Free Cash Flow Per Share | -15.97 | -108.11 | -79.54 | -49.05 |
| EBITDA | -168.51 | -82.25 | -56.73 | -30.67 |
| D&A For EBITDA | 0.58 | 0.7 | 0.56 | 0.57 |
| EBIT | -169.08 | -82.95 | -57.28 | -31.25 |
Source: S&P Capital IQ. Standard template.
Financial Sources.